Ispecimen launches new virtual cancer sequencing procurement program

Program to provide cancer researchers with direct access to highly sought donor tumor tissue samples virtual inventory comprised of formalin-fixed, paraffin-embedded (ffpe) samples screened for mutations lexington, mass., aug. 30, 2023 (globe newswire) -- ispecimen inc.  (nasdaq: ispc) (“ispecimen” or the “company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today the launch of a new program that gives researchers consistent and direct access to mutation-characterized formalin-fixed, paraffin-embedded (“ffpe”) cancer tumor tissues, relieving a major bottleneck in cancer research.
ISPC Ratings Summary
ISPC Quant Ranking